A Phase 3 open-label, multicenter study of the safety, efficacy and pharmacokinetics of intravenous recombinant coagulation Factor VIII Fc-von Willebrand Factor-XTEN fusion protein (rFVIIIFc-VWF-XTEN; BIVV001) in previously treated pediatric patients <12 years of age (EFC16295)with severe hemophilia A | AVESİS

İstanbul Üniversitesi Akademik Veri Yönetim Sistemi

A Phase 3 open-label, multicenter study of the safety, efficacy and pharmacokinetics of intravenous recombinant coagulation Factor VIII Fc-von Willebrand Factor-XTEN fusion protein (rFVIIIFc-VWF-XTEN; BIVV001) in previously treated pediatric patients <12 years of age (EFC16295)with severe hemophilia A

Zülfikar O. B. (Yürütücü), Koç Şenol S. B.

Diğer Uluslararası Fon Programları, 2021 - 2023

Proje Türü: Diğer Uluslararası Fon Programları
Başlama Tarihi: Haziran 2021
Bitiş Tarihi: Mayıs 2023